Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 5, 2011, Pages 1278-1287

  Ohba, Shigeo ^a   Kobayashi, Masahito ^b   Horiguchi, Takashi ^a   Onozuka, Satoshi ^a   Yoshida, Kazunari ^a   Ohira, Takayuki ^a   Kawase, Takeshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

MIB 1 index; p53; Progression; Radiation therapy; Skull base meningioma

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEUROSURGERY; OVERALL SURVIVAL; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SKULL BASE MENINGIOMA; SKULL TUMOR; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM, RESIDUAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SKULL BASE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 79955653747     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.11.JNS10701     Document Type: Article

References (65)

1. Adachi K, Kawase T, Yoshida K, Yazaki T, Onozuka S: ABC Surgical Risk Scale for skull base meningioma: a new scoring system for predicting the extent of tumor removal and neurological outcome. Clinical article. J Neurosurg 111:1053-1061, 2009
2. Aichholzer M, Bertalanffy A, Dietrich W, Roessler K, Pfisterer W, Ungersboeck K, et al: Gamma knife radiosurgery of skull base meningiomas. Acta Neurochir (Wien) 142:647-653, 2000 (Pubitemid 30364690)
3. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M: Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210-218, 2004 (Pubitemid 38970995)
4. Amatya VJ, Takeshima Y, Inai K: Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation. Mod Pathol 17:705-710, 2004 (Pubitemid 38715495)
5. Arai H, Beppu T, Wada T, Yoshida Y, Kubo Y, Suzuki M, et al: Pathological analyses of early recurrence and malignant transformation in meningiomas. Brain Tumor Pathol 15:37-40, 1998
6. Ayerbe J, Lobato RD, de la Cruz J, Alday R, Rivas JJ, Gómez PA, et al: Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 141:921-932, 1999 (Pubitemid 29462215)
7. Bambakidis NC, Kakarla UK, Kim LJ, Nakaji P, Porter RW, Daspit CP, et al: Evolution of surgical approaches in the treatment of petroclival meningiomas: a retrospective review. Neurosurgery 61 (5 Suppl 2):202-211, 2007
8. Bondy M, Ligon BL: Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29:197-205, 1996 (Pubitemid 26254335)
9. Couldwell WT, Fukushima T, Giannotta SL, Weiss MH: Petroclival meningiomas: surgical experience in 109 cases. J Neu rosurg 84:20-28, 1996 (Pubitemid 26006992)
10. Dufour H, Muracciole X, Métellus P, Régis J, Chinot O, Grisoli F: Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery 48:285-296, 2001 (Pubitemid 32164866)
11. Ellison DW, Lunec J, Gallagher PJ, Steart PV, Jaros E, Gatter KC: Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 21:136-142, 1995
12. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715, 1984 (Pubitemid 14035254)
13. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873, 1991
14. Hahn BM, Schrell UM, Sauer R, Fahlbusch R, Ganslandt O, Grabenbauer GG: Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study. J Neurooncol 74:157-165, 2005 (Pubitemid 41478912)
15. Ho DM, Hsu CY, Ting LT, Chiang H: Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538-1547, 2002 (Pubitemid 34212649)
16. Ildan F, Erman T, Göçer AI, Tuna M, Bǎdatǒlu H, Cetinalp E, et al: Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up. Skull Base 17:157-171, 2007
17. Iwai Y, Yamanaka K, Ishiguro T: Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 52:517-524, 2003 (Pubitemid 36258999)
18. Johnson MD, Sade B, Milano MT, Lee JH, Toms SA: New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol 86:109-122, 2008 (Pubitemid 350263440)
19. Kim YJ, Ketter R, Henn W, Zang KD, Steudel WI, Feiden W: Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Arch 449:529-538, 2006 (Pubitemid 44722321)
20. Konstantinidou AE, Pavlopoulos PM, Patsouris E, Kaklamanis L, Davaris P: Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186:325-330, 1998 (Pubitemid 28494363)
21. Korshunov A, Shishkina L, Golanov A: Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome. Int J Cancer 104:728-734, 2003 (Pubitemid 36418510)
22. Lamszus K, Kluwe L, Matschke J, Meissner H, Laas R, Westphal M: Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110:103-110, 1999 (Pubitemid 29181515)
23. Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD: Stereotactic radiosurgery providing longterm tumor control of cavernous sinus meningiomas. J Neurosurg 97:65-72, 2002 (Pubitemid 34693701)
24. Leonetti JP, Anderson DE, Marzo SJ, Origitano TC, Schuman R: Combined transtemporal access for large (>3 cm) meningiomas of the cerebellopontine angle. Otolaryngol Head Neck Surg 134:949-952, 2006 (Pubitemid 43766565)
25. Li X, Liu M, Liu Y, Zhu S: Surgical management of Tuberculum sellae meningiomas. J Clin Neurosci 14:1150-1154, 2007 (Pubitemid 350102784)
26. Little KM, Friedman AH, Sampson JH, Wanibuchi M, Fukushima T: Surgical management of petroclival meningiomas: defining resection goals based on risk of neurological morbidity and tumor recurrence rates in 137 patients. Neurosurgery 56:546-559, 2005
27. Lunsford LD: Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal? J Neurosurg 80:187-190, 1994
28. Maier H, Ofner D, Hittmair A, Kitz K, Budka H: Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616-623, 1992
29. Maiuri F, De Caro Mdel B, Esposito F, Cappabianca P, Strazzullo V, Pettinato G, et al: Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol 82:63-68, 2007
30. Mathiesen T, Lindquist C, Kihlström L, Karlsson B: Recurrence of cranial base meningiomas. Neurosurgery 39:2-9, 1996 (Pubitemid 26230452)
31. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, et al: Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504-510, 1996 (Pubitemid 26133662)
32. Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, et al: Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106:776-781, 1996 (Pubitemid 27009496)
33. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, et al: Factors associated with survival in patients with meningioma. J Neurosurg 88:831-839, 1998 (Pubitemid 28215146)
34. Metellus P, Regis J, Muracciole X, Fuentes S, Dufour H, Nanni I, et al: Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery 57:873-886, 2005
35. Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D: Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg 90:42-49, 1999 (Pubitemid 29024738)
36. Nagashima G, Aoyagi M, Yamamoto M, Yamamoto S, Wakimoto H, Ohno K, et al: P53 overexpression and proliferative potential in malignant meningiomas. Acta Neurochir (Wien) 141:53-61, 1999 (Pubitemid 29062733)
37. Nakamura M, Roser F, Jacobs C, Vorkapic P, Samii M: Medial sphenoid wing meningiomas: clinical outcome and recurrence rate. Neurosurgery 58:626-639, 2006
38. Nakamura M, Roser F, Struck M, Vorkapic P, Samii M: Tuberculum sellae meningiomas: clinical outcome considering different surgical approaches. Neurosurgery 59:1019-1029, 2006
39. Nakasu S, Fukami T, Nakajima M, Watanabe K, Ichikawa M, Matsuda M: Growth pattern changes of meningiomas: longterm analysis. Neurosurgery 56:946-955, 2005
40. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M: Signifi- cance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 25:472-478, 2001 (Pubitemid 32240886)
41. Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J: Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 90:455-462, 1999 (Pubitemid 29104592)
42. Pamir MN, Belirgen M, Ozduman K, Kiliç T, Ozek M: Anterior clinoidal meningiomas: analysis of 43 consecutive surgically treated cases. Acta Neurochir (Wien) 150:625-636, 2008
43. Park CK, Jung HW, Kim JE, Paek SH, Kim DG: The selection of the optimal therapeutic strategy for petroclival meningiomas. Surg Neurol 66:160-166, 2006
44. Park CK, Jung HW, Yang SY, Seol HJ, Paek SH, Kim DG: Surgically treated tuberculum sellae and diaphragm sellae meningiomas: the importance of short-term visual outcome. Neu rosurgery 59:238-243, 2006 (Pubitemid 44325842)
45. Perry A, Louis DN, Scheithauer BW, Budka H, Von Deimling A: Meningiomas, in Louis DN, Ohgaki H, Wiestler OD, et al (eds): WHO Classification of Tumors of the Central Nervous System, ed 4. Lyon: IARC, 2007, pp 164-172
46. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC: "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046-2056, 1999 (Pubitemid 29202781)
47. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455-1465, 1997 (Pubitemid 27528256)
48. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269, 1998 (Pubitemid 28240835)
49. Puzzilli F, Ruggeri A, Mastronardi L, Agrillo A, Ferrante L: Anterior clinoidal meningiomas: report of a series of 33 patients operated on through the pterional approach. Neuro Oncol 1:188-195, 1999
50. Rezanko T, Akkalp AK, Tunakan M, Sari AA: MIB-1 counting methods in meningiomas and agreement among pathologists. Anal Quant Cytol Histol 30:47-52, 2008 (Pubitemid 351312100)
51. Rohringer M, Sutherland GR, Louw DF, Sima AA: Incidence and clinicopathological features of meningioma. J Neurosurg 71:665-672, 1989 (Pubitemid 19275763)
52. Roser F, Samii M, Ostertag H, Bellinzona M: The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37-44, 2004 (Pubitemid 38186205)
53. Saberi H, Meybodi AT, Rezai AS: Levine-Sekhar grading system for prediction of the extent of resection of cranial base meningiomas revisited: study of 124 cases. Neurosurg Rev 29:138-144, 2006
54. Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH: World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery 61:1194-1198, 2007
55. Sekhar LN, Jannetta PJ: Cerebellopontine angle meningiomas. Microsurgical excision and follow-up results. J Neurosurg 60:500-505, 1984 (Pubitemid 14194094)
56. Sekhar LN, Swamy NK, Jaiswal V, Rubinstein E, Hirsch WE Jr, Wright DC: Surgical excision of meningiomas involving the clivus: preoperative and intraoperative features as predictors of postoperative functional deterioration. J Neurosurg 81:860-868, 1994 (Pubitemid 24373466)
57. Shin M, Kurita H, Sasaki T, Kawamoto S, Tago M, Kawahara N, et al: Analysis of treatment outcome after stereotactic radiosurgery for cavernous sinus meningiomas. J Neurosurg 95:435-439, 2001 (Pubitemid 32781495)
58. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957
59. Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, et al: Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73:936-942, 1998
60. Terzi A, Saglam EA, Barak A, Soylemezoglu F: The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays. Pathol Res Pract 204:305-314, 2008
61. Voss NF, Vrionis FD, Heilman CB, Robertson JH: Meningiomas of the cerebellopontine angle. Surg Neurol 53:439-447, 2000 (Pubitemid 30386893)
62. Wang JL, Zhang ZJ, Hartman M, Smits A, Westermark B, Muhr C, et al: Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer 64:223-228, 1995
63. Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW: Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psy chiatry 79:574-580, 2008 (Pubitemid 351571878)
64. Zachenhofer I, Wolfsberger S, Aichholzer M, Bertalanffy A, Roessler K, Kitz K, et al: Gamma-knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years. Neurosurgery 58:28-36, 2006 (Pubitemid 43053698)
65. Zentner J, Meyer B, Vieweg U, Herberhold C, Schramm J: Petroclival meningiomas: is radical resection always the best option? J Neurol Neurosurg Psychiatry 62:341-345, 1997 (Pubitemid 27199104)